These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 9690478)
1. Crystal structure of the first three domains of the type-1 insulin-like growth factor receptor. Garrett TP; McKern NM; Lou M; Frenkel MJ; Bentley JD; Lovrecz GO; Elleman TC; Cosgrove LJ; Ward CW Nature; 1998 Jul; 394(6691):395-9. PubMed ID: 9690478 [TBL] [Abstract][Full Text] [Related]
2. Solution structure of ectodomains of the insulin receptor family: the ectodomain of the type 1 insulin-like growth factor receptor displays asymmetry of ligand binding accompanied by limited conformational change. Whitten AE; Smith BJ; Menting JG; Margetts MB; McKern NM; Lovrecz GO; Adams TE; Richards K; Bentley JD; Trewhella J; Ward CW; Lawrence MC J Mol Biol; 2009 Dec; 394(5):878-92. PubMed ID: 19835884 [TBL] [Abstract][Full Text] [Related]
3. Insulin receptor structure and its implications for the IGF-1 receptor. Lawrence MC; McKern NM; Ward CW Curr Opin Struct Biol; 2007 Dec; 17(6):699-705. PubMed ID: 17851071 [TBL] [Abstract][Full Text] [Related]
4. Characterization of a comparative model of the extracellular domain of the epidermal growth factor receptor. Jorissen RN; Epa VC; Treutlein HR; Garrett TP; Ward CW; Burgess AW Protein Sci; 2000 Feb; 9(2):310-24. PubMed ID: 10716183 [TBL] [Abstract][Full Text] [Related]
6. Structural insights into ligand-induced activation of the insulin receptor. Ward C; Lawrence M; Streltsov V; Garrett T; McKern N; Lou MZ; Lovrecz G; Adams T Acta Physiol (Oxf); 2008 Jan; 192(1):3-9. PubMed ID: 18171424 [TBL] [Abstract][Full Text] [Related]
7. Crystallization of the first three domains of the human insulin-like growth factor-1 receptor. McKern NM; Lou M; Frenkel MJ; Verkuylen A; Bentley JD; Lovrecz GO; Ivancic N; Elleman TC; Garrett TP; Cosgrove LJ; Ward CW Protein Sci; 1997 Dec; 6(12):2663-6. PubMed ID: 9416620 [TBL] [Abstract][Full Text] [Related]
8. Model for the complex between the insulin-like growth factor I and its receptor: towards designing antagonists for the IGF-1 receptor. Epa VC; Ward CW Protein Eng Des Sel; 2006 Aug; 19(8):377-84. PubMed ID: 16772308 [TBL] [Abstract][Full Text] [Related]
9. Complex with a phage display-derived peptide provides insight into the function of insulin-like growth factor I. Schaffer ML; Deshayes K; Nakamura G; Sidhu S; Skelton NJ Biochemistry; 2003 Aug; 42(31):9324-34. PubMed ID: 12899619 [TBL] [Abstract][Full Text] [Related]
10. Structural changes in insulin-like growth factor (IGF) I mutant proteins affecting binding kinetic rates to IGF binding protein 1 and IGF-I receptor. Jansson M; Uhlen M; Nilsson B Biochemistry; 1997 Apr; 36(14):4108-17. PubMed ID: 9100004 [TBL] [Abstract][Full Text] [Related]
11. Structural basis for the regulation of insulin-like growth factors by IGF binding proteins. Siwanowicz I; Popowicz GM; Wisniewska M; Huber R; Kuenkele KP; Lang K; Engh RA; Holak TA Structure; 2005 Jan; 13(1):155-67. PubMed ID: 15642270 [TBL] [Abstract][Full Text] [Related]
13. Cys 786 and Cys 776 in the posttranslational processing of the insulin and IGF-I receptors. Maggi D; Cordera R Biochem Biophys Res Commun; 2001 Jan; 280(3):836-41. PubMed ID: 11162597 [TBL] [Abstract][Full Text] [Related]
14. Structural relationships between the insulin receptor and epidermal growth factor receptor families and other proteins. Ward CW; Garrett TP Curr Opin Drug Discov Devel; 2004 Sep; 7(5):630-8. PubMed ID: 15503865 [TBL] [Abstract][Full Text] [Related]
15. Identification of structural characteristics that contribute to a difference in antiapoptotic function between human insulin and insulin-like growth factor 1 receptors. Chen H; Yan GC; Gishizky ML Cell Growth Differ; 1998 Nov; 9(11):939-47. PubMed ID: 9831246 [TBL] [Abstract][Full Text] [Related]
17. Mapping of the insulin-like growth factor II binding site of the Type I insulin-like growth factor receptor by alanine scanning mutagenesis. Sørensen H; Whittaker L; Hinrichsen J; Groth A; Whittaker J FEBS Lett; 2004 May; 565(1-3):19-22. PubMed ID: 15135045 [TBL] [Abstract][Full Text] [Related]
18. Differential regulation of signaling pathways for insulin and insulin-like growth factor I. Lopaczynski W Acta Biochim Pol; 1999; 46(1):51-60. PubMed ID: 10453981 [TBL] [Abstract][Full Text] [Related]
19. Biochemical and structural characterization of a novel class of inhibitors of the type 1 insulin-like growth factor and insulin receptor kinases. Bell IM; Stirdivant SM; Ahern J; Culberson JC; Darke PL; Dinsmore CJ; Drakas RA; Gallicchio SN; Graham SL; Heimbrook DC; Hall DL; Hua J; Kett NR; Kim AS; Kornienko M; Kuo LC; Munshi SK; Quigley AG; Reid JC; Trotter BW; Waxman LH; Williams TM; Zartman CB Biochemistry; 2005 Jul; 44(27):9430-40. PubMed ID: 15996097 [TBL] [Abstract][Full Text] [Related]
20. Insulin and epidermal growth factor receptors contain the cysteine repeat motif found in the tumor necrosis factor receptor. Ward CW; Hoyne PA; Flegg RH Proteins; 1995 Jun; 22(2):141-53. PubMed ID: 7567962 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]